Assignee
STCUBE & CO INC
KR·5 granted patents·8 pending applications·2 citations·filing 2016–2025
Top patents by PatentIndex Score
13 records- 0175US11542331B2Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or BTN1A1-ligandsSTCUBE & CO INC·Filed 2018·Granted Jan 3, 2023·1 cites·18 claims
- 0274US2025129159A1Methods of treating cancer using antibodies and molecules that immunospecifically bind to btn1a1STCUBE & CO INC·Filed 2024·Application pending·0 cites
- 0373US2024343797A1Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereofSTCUBE & CO INC·Filed 2024·Application pending·0 cites
- 0472US10875920B2Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereofSTCUBE & CO INC·Filed 2016·Granted Dec 29, 2020·1 cites·11 claims
- 0571US2025059276A1Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereofSTCUBE & CO INC·Filed 2024·Application pending·0 cites
- 0668US2025327803A1Screening methods for targets for cancer therapySTCUBE & CO INC·Filed 2025·Application pending·0 cites
- 0766US2023279112A1Methods of treating cancer using antibodies and molecules that bind to btn1a1 or btn1a1-ligandsSTCUBE & CO INC·Filed 2022·Application pending·0 cites
- 0861US11970534B2Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereofSTCUBE & CO INC·Filed 2020·Granted Apr 30, 2024·0 cites·13 claims
- 0958US2025189530A1Btn1a1 binding proteins and methods of use thereofSTCUBE & CO INC·Filed 2023·Application pending·0 cites
- 1057US12215151B2Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1STCUBE & CO INC·Filed 2018·Granted Feb 4, 2025·0 cites·20 claims
- 1150US2020148768A1Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereofSTCUBE & CO INC·Filed 2018·Application pending·0 cites
- 1243US12059474B2Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteinsSTCUBE & CO INC·Filed 2017·Granted Aug 13, 2024·0 cites·22 claims
- 1342US2018156800A1Screening methods for targets for cancer therapySTCUBE & CO INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when STCUBE & CO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →